Zhang, Yanting <br/><br/>
Targeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdA.  [electronic resource] 

 -  Molecular cancer therapeutics  07 2016 
 - 1504-14 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-15-0999  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Cell Movement--genetics<br/>Cell Transformation, Neoplastic--drug effects<br/>Disease Models, Animal<br/>Docetaxel<br/>Drug Synergism<br/>Epithelial-Mesenchymal Transition--genetics<br/>Gene Knockdown Techniques<br/>Humans<br/>I-kappa B Kinase--genetics<br/>Male<br/>Mechanistic Target of Rapamycin Complex 1<br/>Mice<br/>Multiprotein Complexes--metabolism<br/>NF-kappa B--genetics<br/>Neoplastic Stem Cells--drug effects<br/>Phosphorylation<br/>Prostatic Neoplasms--genetics<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Signal Transduction--drug effects<br/>TOR Serine-Threonine Kinases--metabolism<br/>Taxoids--pharmacology<br/>Xenograft Model Antitumor Assays